Texas Health Reports Death of Ebola Patient Thomas Duncan (CMRX) (TKMR)
Tweet
Share
E-mail
Get Alerts TKMR Hot Sheet
Join SI Premium – FREE
(Updated - October 8, 2014 11:22 AM EDT)
UPDATE - Texas Health Resources said in a statement today:
It is with profound sadness and heartfelt disappointment that we must inform you of the death of Thomas Eric Duncan this morning at 7:51 a.m.
Mr. Duncan succumbed to an insidious disease, Ebola. He fought courageously in this battle.
Our professionals, the doctors and nurses in the unit, as well as the entire Texas Health Presbyterian Hospital Dallas community, are also grieving his passing. We have offered the family our support and condolences at this difficult time.
Duncan was said to be receiving an experimental drug from Chimerix (Nasdaq: CMRX). Tekmira Pharmaceuticals (Nasdaq: TKMR) also has an experimental drug but it doesn't appear it was used in this case.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Spotify (SPOT) jumps 10% as Q1 revenue, gross margins beat Street's estimates
- Super Micro Computer (SMCI) now down nearly 20%
- Texas Instruments (TXN) jumps as on earnings, revenue beat in fiscal Q1
Create E-mail Alert Related Categories
FDA, Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
